| 2026 |
Thianhlun, P. C. K., Sylvester, C. L., Sawyer, R. K., Wardill, H. R., Stringer, A. M., & Anderson, P. H. (2026). Targeted deletion of Cyp24a1 in the intestine reduces mucosal injury and preserves epithelial proliferation after 5-fluorouracil treatment. Journal of Steroid Biochemistry and Molecular Biology, 255(106857), 10 pages. DOI |
| 2024 |
Sluggett, J. K., Stasinopoulos, J., Sylvester, C., Wong, W. J., Hillen, J., Hughes, G. A., . . . Soulsby, N. (2024). Simplifying medication regimens for residents of aged care facilities: Pharmacist and physician use of a structured five-step medication simplification tool. Research in Social and Administrative Pharmacy, 20(8), 733-739. DOI Scopus1 WoS1 Europe PMC1 |
| 2022 |
Alshabrawy, A. K., Cui, Y., Sylvester, C., Yang, D., Petito, E. S., Barratt, K. R., . . . Anderson, P. H. (2022). Therapeutic Potential of a Novel Vitamin D3 Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding. Biomolecules, 12(7), 1-14. DOI Scopus7 WoS8 Europe PMC8 |
| 2020 |
Sylvester, C. L., Anderson, P. H., & Stringer, A. M. (2020). New therapeutic strategies for combatting gastrointestinal toxicity. Current Opinion in Supportive and Palliative Care, 14(2), 142-152. DOI Scopus5 WoS4 Europe PMC3 |
| 2019 |
Hassanshahi, M., Anderson, P. H., Sylvester, C. L., & Stringer, A. M. (2019). Highlight article: Current evidence for vitamin D in intestinal function and disease. Experimental Biology and Medicine, 244(12), 1040-1052. DOI Scopus13 WoS12 Europe PMC6 |